Showing results (321-330 of 347) with videos related to
Sort By:
Pageof 35
AIDS (London, England)|February 1, 1990
Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2L Ayres, F Avillez, A Garcia-Benito, et al.Liver|December 5, 1997
GB virus C infection in patients who underwent liver transplantationR S Ross, S Viazov, J P Kruppenbacher, et al.Klinische Padiatrie|September 14, 2011
Pandemic A/H1N1(2009) influenza infections in very-low-birth-weight infants--a case series from the German Neonatal NetworkA Stein, M Keller, S Ross, et al.Annals of the Rheumatic Diseases|July 17, 2001
Prevalence of TTV DNA and GBV-C RNA in patients with systemic sclerosis, rheumatoid arthritis, and osteoarthritis does not differ from that in healthy blood donorsC A Seemayer, S Viazov, M Neidhart, et al.Journal of Medical Virology|January 1, 1978
Detection of HBeAg and anti-HBe in acute hepatitis B by a sensitive radioimmunoassayG G Frösner, M Brodersen, G Papaevangelou, et al.Journal of Medical Virology|January 1, 1981
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitisG Pastore, P Dentico, G Angarano, et al.International Journal of Medical Microbiology : IJMM|September 20, 2015
Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assayNico Grüner, S Viazov, K Korn, et al.Vaccine|June 22, 2012
Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, YemenT A Sallam, Y A Raja'a, S Bahaj, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|October 23, 2001
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot studyJ Hillenkamp, T Reinhard, R S Ross, et al.Deutsche Medizinische Wochenschrift (1946)|March 21, 1986
[HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS]P Hengster, H G Blecha, F Deinhardt, et al.Pageof 35